Biomx Inc logo

PHGE - Biomx Inc News Story

$6.36 -0.4  -5.6%

Last Trade - 16/04/21

Sector
Healthcare
Size
Small Cap
Market Cap £256.2m
Enterprise Value £215.5m
Revenue £n/a
Position in Universe 3937th / 6850

BRIEF-BiomX Announces Dosing Of First Subject In Phase 2 Study Of BX001

Tue 2nd March, 2021 12:29pm
March 2 (Reuters) - Biomx Inc  PHGE.A :
    * BIOMX ANNOUNCES DOSING OF FIRST SUBJECT IN PHASE 2 STUDY
OF
BX001 FOR ACNE-PRONE SKIN
    * BIOMX INC - INTERIM DATA READOUT EXPECTED IN Q3 OF 2021

Source text for Eikon:  ID:nBw1rpqKda 
Further company coverage:  PHGE.A 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.